News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
The global benchmarking company STEM Healthcare (STEM) named Daisaburo Sakurai as senior vice president and representative director of Japan.
Previously, Daisaburo was director and head of Biogen’s neurology business unit in Japan. He has more than 24 years of experience in the global pharmaceutical industry and several leadership positions in Japan and Canada at Bayer.
Daisaburo said: “It is a privilege to be joining STEM as the senior vice president and representative director in Japan at such an exciting time. I am thrilled to work with STEM’s innovative and talented team as we work for helping Pharma companies to accelerate their performance. I am sure that we will become the best partner for them, and developing the ‘new era’ of STEM in Japan with a sustainable growth.”